We are live on ! Find out more
KOC

Koss-Olinger Consulting Portfolio holdings

AUM $1.19B
1-Year Est. Return 15.91%
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
+15.91%
3 Year Est. Return
+50.95%
5 Year Est. Return
+57.89%
10 Year Est. Return
AUM
$649M
AUM Growth
+$35M
Cap. Flow
+$5.38M
Cap. Flow %
0.83%
Top 10 Hldgs %
70.02%
Holding
266
New
37
Increased
83
Reduced
80
Closed
51

Sector Composition

Rank Sector Weight
1 Healthcare 2.71%
2 Technology 1.98%
3 Financials 1.45%
4 Consumer Staples 1.43%
5 Communication Services 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHB icon
51
Invesco S&P 500 High Beta ETF
SPHB
$947M
$1.05M 0.16%
13,348
-3,143
-19% -$245K
APD icon
52
Air Products & Chemicals
APD
$65.4B
$1.04M 0.16%
3,411
+1,127
+49% +$331K
XLK icon
53
State Street Technology Select Sector SPDR ETF
XLK
$111B
$1.03M 0.16%
11,864
+1,024
+9% +$84.3K
LHX icon
54
L3Harris
LHX
$55.8B
$1.01M 0.16%
4,734
GOOG icon
55
Alphabet (Google) Class C
GOOG
$4.15T
$1M 0.15%
6,940
-200
-3% -$28.9K
VOD icon
56
Vodafone
VOD
$37.3B
$959K 0.15%
64,263
+27,023
+73% +$412K
XSOE icon
57
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$1.96B
$942K 0.15%
25,562
-1,425
-5% -$53.6K
MAC icon
58
Macerich
MAC
$7.5B
$938K 0.14%
54,272
-957
-2% -$17.9K
JNJ icon
59
Johnson & Johnson
JNJ
$641B
$890K 0.14%
5,203
-544
-9% -$89.1K
COP icon
60
ConocoPhillips
COP
$144B
$888K 0.14%
12,304
+5,065
+70% +$369K
IONS icon
61
Ionis Pharmaceuticals
IONS
$8.98B
$887K 0.14%
29,161
+17,729
+155% +$558K
PARA
62
DELISTED
Paramount Global Class B
PARA
$886K 0.14%
29,355
-1,819
-6% -$62.7K
K
63
DELISTED
Kellanova
K
$860K 0.13%
14,225
-1,800
-11% -$106K
STZ icon
64
Constellation Brands
STZ
$22.5B
$853K 0.13%
3,400
+1,885
+124% +$430K
AIRC
65
DELISTED
Apartment Income REIT Corp.
AIRC
$848K 0.13%
15,516
-302
-2% -$15.8K
WELL icon
66
Welltower
WELL
$173B
$844K 0.13%
9,836
-185
-2% -$15.4K
SPSB icon
67
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$836K 0.13%
27,009
+1,006
+4% +$31.2K
VGSH icon
68
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$831K 0.13%
13,654
+498
+4% +$30.5K
QQQ icon
69
Invesco QQQ Trust
QQQ
$442B
$830K 0.13%
2,085
-2,580
-55% -$996K
SPY icon
70
State Street SPDR S&P 500 ETF Trust
SPY
$779B
$764K 0.12%
+1,609
New +$739K
CGW icon
71
Invesco S&P Global Water Index ETF
CGW
$1.05B
$756K 0.12%
12,475
+1,813
+17% +$107K
AGG icon
72
iShares Core US Aggregate Bond ETF
AGG
$138B
$733K 0.11%
+6,427
New +$735K
HBI
73
DELISTED
Hanesbrands
HBI
$718K 0.11%
42,929
+3,098
+8% +$52.7K
TSLA icon
74
Tesla
TSLA
$1.2T
$709K 0.11%
2,013
-23,943
-92% -$8.03M
TXG icon
75
10x Genomics
TXG
$5.97B
$709K 0.11%
4,763
-300
-6% -$46K

Similar funds

Koss-Olinger Consulting's Q4 2021 Portfolio in Review

As of Q4 2021, Koss-Olinger Consulting held 266 positions worth $649M, up 5.7% from $614M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Koss-Olinger Consulting's Q4 2021 filing shows 37 new, 83 increased, 80 reduced and 51 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 40,760 shares worth $2.02M. The largest sale was VanEck Emerging Markets High Yield Bond ETF, an estimated $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, down from 3.2% a quarter earlier, followed by Technology and Financials.

  • Koss-Olinger Consulting's largest Q4 2021 buy was Vanguard FTSE Emerging Markets ETF: 40,760 shares worth $2.02M.
  • Koss-Olinger Consulting added most to Vanguard Total Bond Market in Q4 2021, an estimated $36.2M increase.
  • Koss-Olinger Consulting's biggest Q4 2021 reduction was VanEck Emerging Markets High Yield Bond ETF, cutting an estimated $34.6M.
  • Koss-Olinger Consulting fully exited Arcturus Therapeutics in Q4 2021, selling an estimated $2.09M.
  • Koss-Olinger Consulting's ten largest holdings make up 70% of its $649M portfolio in Q4 2021.
  • Koss-Olinger Consulting opened 37 new positions and closed 51 in Q4 2021.
  • Koss-Olinger Consulting's portfolio value rose 5.7% quarter-over-quarter to $649M.

Based on Koss-Olinger Consulting's 13F filing for Q4 2021, filed 7 Feb 2022.